519 related articles for article (PubMed ID: 3079606)
1. Prostaglandins as endogenous mediators of interleukin 1 production.
Kunkel SL; Chensue SW; Phan SH
J Immunol; 1986 Jan; 136(1):186-92. PubMed ID: 3079606
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
[TBL] [Abstract][Full Text] [Related]
3. Regulation of murine mononuclear phagocyte inflammatory products by macrophage colony-stimulating factor. Lack of IL-1 and prostaglandin E2 production and generation of a specific IL-1 inhibitor.
Strassmann G; Bertolini DR; Kerby SB; Fong M
J Immunol; 1991 Aug; 147(4):1279-85. PubMed ID: 1869823
[TBL] [Abstract][Full Text] [Related]
4. Regulation of B cell tolerance by macrophage-derived mediators: antagonistic effects of prostaglandin E2 and interleukin 1.
Goldings EA
J Immunol; 1986 Feb; 136(3):817-22. PubMed ID: 2416834
[TBL] [Abstract][Full Text] [Related]
5. Regulation of macrophage-derived fibroblast growth factor release by arachidonate metabolites.
Phan SH; McGarry BM; Loeffler KM; Kunkel SL
J Leukoc Biol; 1987 Aug; 42(2):106-13. PubMed ID: 3036988
[TBL] [Abstract][Full Text] [Related]
6. Regulation of lipopolysaccharide-induced tumor necrosis factor alpha production by endogenous prostaglandin E2 in rat resident and thioglycollate-elicited macrophages.
Watanabe S; Kobayashi T; Okuyama H
J Lipid Mediat Cell Signal; 1994 Sep; 10(3):283-94. PubMed ID: 7812678
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E is required for the augmentation of procoagulant activity of LPS-stimulated rabbit alveolar macrophages.
Sitrin RG; Kaltreider HB; Goldyne ME
J Immunol; 1984 Feb; 132(2):867-71. PubMed ID: 6581228
[TBL] [Abstract][Full Text] [Related]
8. Modulation of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins.
Taupin V; Gogusev J; Descamps-Latscha B; Zavala F
Mol Pharmacol; 1993 Jan; 43(1):64-9. PubMed ID: 8380885
[TBL] [Abstract][Full Text] [Related]
9. Arachidonic acid metabolites regulate interleukin-1 production.
Kunkel SL; Chensue SW
Biochem Biophys Res Commun; 1985 Apr; 128(2):892-7. PubMed ID: 3922370
[TBL] [Abstract][Full Text] [Related]
10. African trypanosomiasis alters prostaglandin production by murine peritoneal macrophages.
Fierer J; Salmon JA; Askonas BA
Clin Exp Immunol; 1984 Dec; 58(3):548-56. PubMed ID: 6391763
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1 beta and TNF-alpha.
Barrios-Rodiles M; Tiraloche G; Chadee K
J Immunol; 1999 Jul; 163(2):963-9. PubMed ID: 10395693
[TBL] [Abstract][Full Text] [Related]
12. The functional significance of the regulation of macrophage Ia expression by endogenous arachidonate metabolites in vitro.
Tripp CS; Wyche A; Unanue ER; Needleman P
J Immunol; 1986 Dec; 137(12):3915-20. PubMed ID: 3097136
[TBL] [Abstract][Full Text] [Related]
13. Modulation of tumor necrosis factor-alpha gene expression. Desensitization of prostaglandin E2-induced suppression.
Spengler RN; Spengler ML; Strieter RM; Remick DG; Larrick JW; Kunkel SL
J Immunol; 1989 Jun; 142(12):4346-50. PubMed ID: 2723432
[TBL] [Abstract][Full Text] [Related]
14. Regulation of thymocyte proliferative response by macrophage-derived prostaglandin E2 and interleukin 1.
Hayari Y; Kukulansky T; Globerson A
Eur J Immunol; 1985 Jan; 15(1):43-7. PubMed ID: 2981690
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production.
Boraschi D; Censini S; Tagliabue A
J Immunol; 1984 Aug; 133(2):764-8. PubMed ID: 6330202
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R
Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032
[TBL] [Abstract][Full Text] [Related]
18. [Prostaglandin E2 and interleukin-1-producing activity of plastic-adherent cells from cancer patients as a result of modification by BRM therapy].
Asai R; Nakao I; Ito K; Ohashi Y; Saito T; Kataoka T
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):922-30. PubMed ID: 3494429
[TBL] [Abstract][Full Text] [Related]
19. Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxygenase.
Habenicht AJ; Goerig M; Grulich J; Rothe D; Gronwald R; Loth U; Schettler G; Kommerell B; Ross R
J Clin Invest; 1985 Apr; 75(4):1381-7. PubMed ID: 3921570
[TBL] [Abstract][Full Text] [Related]
20. Regulation of macrophage-mediated tumor cell killing by prostaglandins: comparison of the effects of PGE2 and PGI2.
Taffet SM; Eurell TE; Russell SW
Prostaglandins; 1982 Dec; 24(6):763-74. PubMed ID: 6300968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
